• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia.

作者信息

Bellusci Lorenza, Grubbs Gabrielle, Srivastava Pragya, Nemeth Michael J, Griffiths Elizabeth A, Golding Hana, Khurana Surender

机构信息

Division of Viral Products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, Silver Spring, MD; and.

Department of Medicine.

出版信息

Blood. 2022 May 5;139(18):2842-2846. doi: 10.1182/blood.2022016087.

DOI:10.1182/blood.2022016087
PMID:35344579
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8964006/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/9074405/fa9d71326540/bloodBLD2022016087f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/9074405/fa9d71326540/bloodBLD2022016087f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08b3/9074405/fa9d71326540/bloodBLD2022016087f1.jpg

相似文献

1
Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia.骨髓增生异常综合征或急性髓系白血病患者接种疫苗后对SARS-CoV-2奥密克戎毒株的中和作用。
Blood. 2022 May 5;139(18):2842-2846. doi: 10.1182/blood.2022016087.
2
Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes.COVID-19 疫苗接种后 T 细胞应答缺陷与急性髓系白血病和骨髓增生异常综合征。
Br J Haematol. 2023 Aug;202(3):498-503. doi: 10.1111/bjh.18894. Epub 2023 Jun 12.
3
Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies.mRNA 新冠疫苗在骨髓恶性肿瘤患者中的体液免疫反应。
Br J Haematol. 2022 Jun;197(6):691-696. doi: 10.1111/bjh.18138. Epub 2022 Mar 14.
4
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemic.评估封锁措施的影响：COVID-19大流行期间血液学患者护理面临的新挑战。
Br J Haematol. 2020 Jun;189(6):e224-e227. doi: 10.1111/bjh.16782. Epub 2020 May 23.
5
Serum Neutralization of SARS-CoV-2 Omicron BA.1 and BA.2 after BNT162b2 Booster Vaccination.接种 BNT162b2 加强针后对 SARS-CoV-2 奥密克戎 BA.1 和 BA.2 的血清中和作用。
Emerg Infect Dis. 2022 Jun;28(6):1274-1275. doi: 10.3201/eid2806.220503. Epub 2022 Mar 31.
6
Myelodysplastic syndrome in a kidney transplant recipient after SARS-CoV-2 infection: can SARS-CoV-2 induce myelodysplastic syndrome?一名感染新型冠状病毒2后肾移植受者发生的骨髓增生异常综合征：新型冠状病毒2能否诱发骨髓增生异常综合征？
Int Urol Nephrol. 2022 Jul;54(7):1775-1776. doi: 10.1007/s11255-021-03069-1. Epub 2021 Nov 23.
7
The Third dose of CoronVac vaccination induces broad and potent adaptive immune responses that recognize SARS-CoV-2 Delta and Omicron variants.科兴新冠疫苗第三针诱导广泛而有效的适应性免疫应答，能识别 SARS-CoV-2 德尔塔和奥密克戎变异株。
Emerg Microbes Infect. 2022 Dec;11(1):1524-1536. doi: 10.1080/22221751.2022.2081614.
8
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间，加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局，期间 B.1.617.2（德尔塔）和 B.1.1.529（奥密克戎）变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
9
Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.在 COVID-19 大流行期间满足非亲缘供者的需求：国家骨髓供者计划及其网络合作伙伴的快速调整确保了供者产品的安全供应。
Transplant Cell Ther. 2021 Feb;27(2):133-141. doi: 10.1016/j.jtct.2020.10.014. Epub 2020 Dec 11.
10
Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS-CoV-2 pandemic.2019冠状病毒病大流行期间骨髓增生异常综合征/骨髓增殖性肿瘤重叠综合征患者管理中的特殊考虑因素
Am J Hematol. 2020 Aug;95(8):E203-E208. doi: 10.1002/ajh.25853. Epub 2020 May 22.

引用本文的文献

1
Longitudinal Study of SARS-CoV-2 Vaccinations and Infections in Patients with Gastrointestinal Cancer: Stabilizing Immune Responses and Neutralizing Emerging Variants with Variant-Adapted Antigen Exposures.胃肠道癌患者中SARS-CoV-2疫苗接种与感染的纵向研究：通过适应性变异抗原暴露稳定免疫反应并中和新出现的变异株
Int J Mol Sci. 2024 Dec 19;25(24):13613. doi: 10.3390/ijms252413613.
2
Severe COVID-19 in Vaccinated Adults With Hematologic Cancers in the Veterans Health Administration.在退伍军人健康管理局中，接种过疫苗的血液系统恶性肿瘤成年患者的严重 COVID-19 。
JAMA Netw Open. 2024 Feb 5;7(2):e240288. doi: 10.1001/jamanetworkopen.2024.0288.
3

本文引用的文献

1
Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies.mRNA 新冠疫苗在骨髓恶性肿瘤患者中的体液免疫反应。
Br J Haematol. 2022 Jun;197(6):691-696. doi: 10.1111/bjh.18138. Epub 2022 Mar 14.
2
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.mRNA-1273 新冠疫苗有效性临床试验的免疫相关性分析。
Science. 2022 Jan 7;375(6576):43-50. doi: 10.1126/science.abm3425. Epub 2021 Nov 23.
3
Effectiveness of the BNT162b2mRNA COVID-19 vaccine in patients with hematological neoplasms in a nationwide mass vaccination setting.
COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches.
COVID-19 与贫血和血液系统恶性肿瘤患者：风险因素、临床指南和新兴治疗方法。
Cell Commun Signal. 2024 Feb 15;22(1):126. doi: 10.1186/s12964-023-01316-9.
4
Multi-omics analysis of mucosal and systemic immunity to SARS-CoV-2 after birth.出生后对 SARS-CoV-2 的黏膜和全身免疫的多组学分析。
Cell. 2023 Oct 12;186(21):4632-4651.e23. doi: 10.1016/j.cell.2023.08.044. Epub 2023 Sep 29.
5
Vaccine schedule recommendations and updates for patients with hematologic malignancy post-hematopoietic cell transplant or CAR T-cell therapy.造血细胞移植或 CAR-T 细胞治疗后血液系统恶性肿瘤患者的疫苗接种计划建议和更新。
Transpl Infect Dis. 2023 Nov;25 Suppl 1(Suppl 1):e14109. doi: 10.1111/tid.14109. Epub 2023 Jul 29.
6
Booster effect of a third mRNA-based COVID-19 vaccine dose in patients with myeloid malignancies.mRNA 疫苗加强针在血液系统恶性肿瘤患者中的效果。
Cancer Med. 2023 Aug;12(16):16881-16888. doi: 10.1002/cam4.6314. Epub 2023 Jul 6.
7
Systems biological assessment of the temporal dynamics of immunity to a viral infection in the first weeks and months of life.对生命最初几周和几个月内病毒感染免疫的时间动态进行系统生物学评估。
medRxiv. 2023 Jan 31:2023.01.28.23285133. doi: 10.1101/2023.01.28.23285133.
8
The Effects of an mRNA Covid-19 Vaccine Booster on Immune Responses in Cancer-Bearing Veterans.mRNA新冠疫苗加强针在患癌退伍军人中对免疫反应的影响。
Med Res Arch. 2022 Jul 31;10(7). doi: 10.18103/mra.v10i7.2932.
9
Comprehensive profiling of the human viral exposome in households containing an at-risk child with mitochondrial disease during the 2020-2021 COVID-19 pandemic.在 2020-2021 年 COVID-19 大流行期间，对含有一名患有线粒体疾病的高危儿童的家庭中的人类病毒外显子组进行全面分析。
Clin Transl Med. 2022 Nov;12(11):e1100. doi: 10.1002/ctm2.1100.
BNT162b2mRNA 新冠疫苗在全国大规模疫苗接种环境中对血液系统恶性肿瘤患者的有效性。
Blood. 2022 Mar 10;139(10):1439-1451. doi: 10.1182/blood.2021013768.
4
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern.严重急性呼吸综合征冠状病毒2型高效价静脉注射用人免疫球蛋白的表位多样性及对关注变异株的中和作用
iScience. 2021 Sep 24;24(9):103006. doi: 10.1016/j.isci.2021.103006. Epub 2021 Aug 20.
5
Immune responses to COVID-19 vaccines in patients with cancer: Promising results and a note of caution.癌症患者对 COVID-19 疫苗的免疫反应：有希望的结果和谨慎的提示。
Cancer Cell. 2021 Aug 9;39(8):1045-1047. doi: 10.1016/j.ccell.2021.07.001. Epub 2021 Jul 3.
6
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell-directed therapies.接受B细胞定向疗法的淋巴瘤患者对新冠疫苗接种的体液免疫反应受损。
Blood. 2021 Sep 2;138(9):811-814. doi: 10.1182/blood.2021012443.
7
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.中和抗体水平高度预测对有症状的 SARS-CoV-2 感染的免疫保护作用。
Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17.
8
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.BNT162b2 mRNA 新冠病毒疫苗在全国大规模疫苗接种环境中的效果。
N Engl J Med. 2021 Apr 15;384(15):1412-1423. doi: 10.1056/NEJMoa2101765. Epub 2021 Feb 24.
9
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients.血液系统恶性肿瘤合并 COVID-19 患者的结局：对 3377 例患者的系统评价和荟萃分析。
Blood. 2020 Dec 17;136(25):2881-2892. doi: 10.1182/blood.2020008824.
10
Risk of infections in patients with myeloproliferative neoplasms-a population-based cohort study of 8363 patients.骨髓增殖性肿瘤患者的感染风险：一项基于人群的 8363 例患者的队列研究。
Leukemia. 2021 Feb;35(2):476-484. doi: 10.1038/s41375-020-0909-7. Epub 2020 Jun 16.